key: cord-0011165-vcpm1sek authors: Albhaisi, Somaya A. M.; Bajaj, Jasmohan S. title: Cognitive Function in Liver Transplantation date: 2020-03-26 journal: Curr Transplant Rep DOI: 10.1007/s40472-020-00274-2 sha: fdde03225667b2f66497b39100371c233f71b6cd doc_id: 11165 cord_uid: vcpm1sek PURPOSE OF REVIEW: Liver transplantation (LT) remains the only way to cure patients with severe liver diseases. Important questions about neurological sequelae and quality of life after LT have emerged. In this review, we discuss the neurocognitive changes associated with LT and we conclude with recommendations in this regard for patients, caregivers, and physicians. RECENT FINDINGS: Compared with other solid organ recipients, LT patients tend to have a higher incidence (up to 30%) of neurological complications post-LT. Even in absence of previous episodes of hepatic encephalopathy (HE), some patients display new onset of neurological symptoms post-LT, raising the concern about the role of other factors that may have a direct impact on cognitive function. SUMMARY: Different mechanisms have been postulated to explain these postoperative neurological symptoms. They include sequelae of HE, persistent impairment of cognitive function due to cirrhosis, or postoperative decompensation of an unknown or undiagnosed neurodegenerative disorder. Hepatic encephalopathy (HE) represents a spectrum of neurocognitive impairment in cirrhosis (SONIC) [1]. It constitutes of two major components: overt HE (OHE) and minimal HE (MHE) [2] . OHE can be diagnosed clinically, whereas MHE requires specialized testing. It has been estimated that OHE is present in 30-45% of patients with cirrhosis [3], compared with approximately 60-80% of patients who have evidence of MHE [4] . MHE can potentially progress to OHE and is associated with high mortality, poor quality of life, and a high risk of motor vehicle accidents [5] . HE continues to pose a major healthcare burden on patients, caregivers, and society [6• ]. It has been reported that the healthcare costs for patients with HE are likely to increase over the coming years [7] . There are several clinical systems to diagnose the severity of HE [8] [9] [10] . However, most of them are subjective and not reproducible because of lack of objective criteria for the clinical diagnosis of HE [11] . The West-Haven criteria are the most widely used; however, they also lack objectivity through the entire spectrum of HE [12] . Other tests that can assist with diagnosing HE are clinical hepatic encephalopathy staging scale (CHESS) [13] and the Hepatic Encephalopathy Scoring Algorithm (HESA) [11] [14] . When making a clinical diagnosis of HE, it is important to exclude other etiologies that can lead to alteration in mental status, and to specifically investigate the cognitive function as well. Deterioration in mental status and in psychometric or neurophysiological function are the two levels of cognitive function that need to be acknowledged given the fact that clinical exam can diagnose mental status changes only. disorder, constipation, and diuretic overdose. Patients with alcohol-related cirrhosis exhibit more severe neurocognitive changes and more cortical lesions post-transjugular intrahepatic portosystemic shunt (TIPS) placement based on brain MRI compared with individuals with cirrhosis from other etiologies [15••] . Recent data suggest that patients with non-alcoholic steatohepatitis (NASH) are at risk for premature brain aging due to the presence of early cerebral atrophy [16] . Large studies have shown an association between hepatitis C virus (HCV) infection and increased risk of neurodegenerative disorders [17] . Global brain reserve is a term that describes a combination of structural changes (brain reserve) and the individual's ability to endure alterations (cognitive reserve) [18] . Changes in global reserve have been shown to impact the progression of brain diseases such as dementia and multiple sclerosis [19, 20] . Cognitive reserve reflects the dynamic neuroadaptation that derives from socio-economic and educational factors. It has been shown to modulate the impact of brain disease or neurocognitive insults such as HE [21••] . In contrast to cognitive reserve, brain reserve is less adaptable and is dependent on disease etiology, severity, and progression [19] . The capacity of brain reserve was reported to be implicated in the lack of direct correlation between the clinical manifestations of brain diseases and the objective findings obtained by imaging or neurophysiological tests [22] . Variables such as education level [23] , psychometrical intelligence [24] , leisure time activities [25] , and lifestyle [26] determine the brain's ability to cope with damage. The expression of HE phenotype is determined by two opposing forces: cognitive reserve (resilience factor) and neuropsychiatric comorbidity (precipitating factor). It has been reported that patients with cirrhosis and higher cognitive reserve, regardless of degree of liver failure, have better quality of life [21••, 27] . The Barona Index is a validated IQ analysis which consists of age, sex, race, education, occupation, residence type (urban or rural), and region of residence (locations within the USA) [28] . It is an optimal method for testing pre-morbid intelligence that follows subject cognitive performance [29] . The Barona IQ is divided into the verbal IQ (VIQ), performance IQ (PIQ), and the full scale IQ (FSIQ). High cognitive reserve is defined as FSIQ ≥ 109 while lower than 109 is considered average cognitive reserve [30] . Cognitive Reserve Index questionnaire (CRIq) is another tool that produces CRI which reflects the amount of cognitive reserve based on educational level, work activities, and frequency of leisure time activities [31] . CRIq is different from the Barona Index because it measures long-life activities that modulate cognitive skills, and can be complimentary to the Barona Index in correlating between IQ and health-related quality of life in patients with cirrhosis [21••] . Liver transplantation (LT) remains the gold standard treatment for HE refractory to other treatments, but it carries risks. It has been shown that manifestations of HE are not completely fully reversible by transplantation as it may induce impairment of brain function [32] . The development of postoperative confusional syndrome is a problem of considerable magnitude due to the difficulty in finding the underlying etiology of alteration in mental status, and the likelihood of presence of multiple causes (Fig. 1) . Patients with recurrent HE before transplantation and those with alcoholic liver disease (ALD) are at higher risk. There is a debate in the presence of HE sequelae after LT even if HE symptoms disappear [33] [34] [35] . This is because several data suggest that LT reverses the metabolic component of HE, but the structural component may persist [36••] . The hypotheses behind this assumption are as follows: hyperammonemia from decompensation due to urea cycle defects can lead to long-term neurological sequelae [34] ; correlation between neurological impairment and history of previous episodes of HE [37, 38] . In contrast, some studies report that HE is totally reversible and that what is thought to be HE sequelae is a manifestation of competitive brain injuries such as from hyperammonemia [39] . Many LT patients have risk factors for neurocognitive changes such as age, alcoholism, and metabolic syndrome, regardless of previous bouts of HE [15••, 16] . An example of a causative factor for post-LT confusion is immunosuppressant drugs because they frequently have toxic effects especially if their blood levels are elevated. Diagnosis of adverse cerebral effects of drugs may be difficult. Infections (bacterial or viral) can result in confusion associated with fever, which requires a diligent workup. In general, altered mental status post-transplant must be approached from a broad clinical view since the etiology is usually multifactorial. The most frequent neurological complications of LT include seizures, stroke, central nervous system (CNS) infections, ICU-acquired weakness, and neurocognitive complications (due to decompensation of previous altered cerebral condition, general anesthesia, surgical procedure, or anticalcineurin toxicity). Factors that can indirectly lead to neurological complications include early graft function impairment, drugs, renal function impairment, sepsis, and altered ammonia clearance [40] . Some patients who have no history of cerebral impairment or previous evidence of HE can develop neurological impairment after LT. It has been suggested that possible causative factors include adverse effects of general anesthesia, the surgery itself, or postoperative ICU stay [41] [42] [43] [44] [45] . There are several causes of ICU admission that are implicated in long-term neurocognitive impairment such as sepsis or acute respiratory distress syndrome [41] [42] [43] 46] . Postoperative cognitive dysfunction has been recognized as a common problem that is independently associated with increased mortality outside the scope of LT [47] . Systemic inflammation has been hypothesized to be a pathophysiological mechanism explaining postoperative cognitive dysfunction or postoperative delirium [44] . The additional inflammation associated with the LT surgery worsens the pre-existing systemic inflammation in acute liver failure (ALF) and cirrhosis. Additional pre-LT risk factors that have been reported include duration of surgery, infections, and mechanical ventilation [48] . Evidence suggests that patients with cirrhosis tend to demonstrate long-lasting cognitive impairment after infection [49] . Other causes for cerebral impairment are the changes in cerebral blood flow and systemic hemodynamics. HE is presumed to be largely reversed after successful LT [50] . Data on long-term cognitive changes post-LT are variable (Table 1) . Some studies have shown a continued improvement in cognitive function, while others have reported the contrary [10, 62•]. These neurocognitive deficits are assessed by extensive psychometric neurocognitive testing and have been confirmed by EEG, different MRI techniques, and positron emission tomography (PET) scanning [52, 62•] . MRI studies that use standard sequences, magnetic resonance spectroscopy (MRS), diffusion tensor imaging (DTI), and functional MRI are capable of showing changes in cerebral abnormalities before and after LT [51] [52] [53] 55] . Only a few studies have investigated the role of multi-modal brain MRI changes over a longer time period and reported conflicting results from longitudinal analyses of these MRI changes [32, 52, 65] . A study analyzed changes in magnetization transfer ratio (marker for brain edema) and MRS, and reported a progressive improvement in both markers between pre-LT, 1 month post-LT, and 1 year post-LT without continued improvement in cognition at 1 year post-LT [62•] . Another study showed improved extracellular cerebral edema and cognitive tests, but also possibly advanced white matter demyelination in the temporal lobe, 6 to 12 months after transplant [65] . It has been reported that there is a significant improvement in cognitive performance and health-related quality of life (HRQOL) at 6 months post-LT, accompanied by a significant improvement in white matter integrity and astrocytic consequences of hyperammonemia on multi-modal MRI [63] . Despite limited data from DTI, it appears that mean diffusivity (MD) decreases after LT, suggesting reversal of vasogenic edema with the improvement of liver function [36••, 59, 61] . It has been reported that MRS peaks can normalize as early as 3 months after LT [52] . Less is known about the results from functional MRI; however, improvement in cerebral function after LT was suggested [61, [66] [67] [68] [69] [70] . On the other hand, there is evidence reporting reduction in brain volume and a decrease in the MRS N-acetylaspartate (NAA)/creatinine (Cr) ratio which suggest the presence of structural brain changes and atrophy [32] . There are practice guidelines that have been published for the management of transplant candidates [71, 72] . HE alone is not considered an indication for LT unless associated with poor liver function. However, exceptions exist where cases may be candidates for LT even though liver status is good if there is year after LT severe compromise to the patient's quality of life and lack of improvement despite maximal medical therapy. Due to the fact that neurocognitive impairment may occur or persist even after LT, it is highly recommended to evaluate for presence of shunts and consider embolization before or during transplantation [73] . Furthermore, during transplant evaluation, severe hyponatremia should be corrected slowly. Based on evidence from published date, LT is expected to improve HE but not neurodegenerative disorders. Therefore, it is important to distinguish HE from other causes of neurocognitive impairment such as Alzheimer's disease and small-vessel cerebrovascular disease. Brain MRI and MRS should be performed, and the patient should be evaluated by a neuropsychology specialist and an expert in neurodegenerative diseases [74] . Patients and caregivers, especially in patients with prior HE and cognitive dysfunction, need to be counseled prior to listing about the expectations for recovery of brain function in the short-term and long-term course post-LT extensively. There are certain subgroups in which complete recovery may take decades, and in some subgroups, it may remain impaired. In some patients, there may even be new-onset cognitive dysfunction after LT. However, in most cases, these changes are manageable and do not interfere with daily function and independence post-LT. Regardless, pre-transplant counseling should involve a discussion regarding cognitive and functional expectations of the family and patients after liver transplant. Figure Copy ; WM, white matter; MHE, minimal hepatic encephalopathy; OHE, overt hepatic encephalopathy; POCD, postoperative cognitive dysfunction; ALD, alcoholic liver disease; CNI, calcineurin inhibitor Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver Review article: the modern management of hepatic encephalopathy The electroencephalograph in liver disease Assessment of coma and impaired consciousness. A practical scale Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy The effect of fatigue on driving skills in patients with hepatic encephalopathy Development of a clinical hepatic encephalopathy staging scale Cognitive dysfunction in chronic hepatitis C: a review The etiology of cirrhosis is a strong determinant of brain reserve: a multimodal magnetic resonance imaging study Association of nonalcoholic fatty liver disease with lower brain volume in healthy middle-aged adults in the Framingham study Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis Brain reserve hypothesis in dementia Cognitive reserve and Alzheimer disease Education attenuates the negative impact of traumatic brain injury on cognitive status This study evaluates the impact of cognitive reserve on personal assessment of health-related quality of life (HRQOL) in the context of liver disease severity and covert HE diagnosis. The study highlights the importance of considering cognitive reserve when interpreting HRQOL Development of dementing illnesses in an 80-year-old volunteer cohort Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis Leisure activities and the risk of dementia in the elderly Influence of education and occupation on the incidence of Alzheimer's disease The hunter and the pianist: two hepatic encephalopathy tales A demographically based index of premorbid intelligence for the WAIS-R Comparison of NART and Barona demographic equation premorbid IQ estimates in Alzheimer's disease. -Abstract -Europe PMC Development of the New Zealand Adult Reading Test (NZART): preliminary findings Cognitive Reserve Index questionnaire (CRIq): a new instrument for measuring cognitive reserve Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume Neurological complications after orthotopic liver transplantation. Dig Liver Dis Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-onchronic liver failure Understanding hepatic encephalopathy Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation Study of MRI changes before and after liver transplant from a diffusion tensor imaging perspective Does overt hepatic encephalopathy cause persistent cognitive defects even after successful liver transplantation? Longterm outcomes for liver transplant recipients in terms of hepatic encephalopathy Impaired cerebral microcirculation induced by ammonium chloride in rats is due to cortical adenosine release Neurological complications occurring after liver transplantation: role of risk factors, hepatic encephalopathy, and acute (on chronic) brain injury Long-term outcomes after critical illness The evolving approach to brain dysfunction in critically ill patients Long-term cognitive impairment after critical illness Understanding brain dysfunction in sepsis Predictors of cognitive dysfunction after major noncardiac surgery Functional disability 5 years after acute respiratory distress syndrome Postoperative cognitive dysfunction after noncardiac surgery: a systematic review Postoperative cognitive dysfunction after liver transplantation Increased risk of cognitive impairment in cirrhotic patients with bacterial infections Neurocognitive-neurological complications of liver transplantation: a review Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant Decreased white matter lesion volume and improved cognitive function after liver transplantation A long-term study of changes in the volume of brain ventricles and white matter lesions after successful liver transplantation Neuropsychological functioning in patients with alcohol-related liver disease before and after liver transplantation Minimal hepatic encephalopathy: follow-up 10 years after successful liver transplantation Increase of beta-amyloid and C-reactive protein in liver transplant recipients with postoperative cognitive dysfunction Clinical and radiological impact of liver transplantation for brain in cirrhosis patients without hepatic encephalopathy New-onset cognitive dysfunction impairs the quality of life in patients after liver transplantation Longitudinal brain white matter alterations in minimal hepatic encephalopathy before and after liver transplantation Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? Liver transplantation significantly improves global functioning and cerebral processing Hepatic encephalopathy before and neurological complications after liver transplantation have no impact on the employment status 1 year after transplantation Systemic inflammation and ammonia in hepatic encephalopathy Reestablishing brain networks in patients without overt hepatic encephalopathy after liver transplantation Liver transplantation nearly normalizes brain spontaneous activity and cognitive function at 1 month: a resting-state functional MRI study Longand short-range functional connectivity density alteration in nonalcoholic cirrhotic patients one month after liver transplantation: a resting-state fMRI study The short-term effect of liver transplantation on the low-frequency fluctuation of brain activity in cirrhotic patients with and without overt hepatic encephalopathy Longitudinal intrinsic brain activity changes in cirrhotic patients before and one month after liver transplantation Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: treatment with embolization of portosystemic collaterals Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations